(E)-2-(2-(pyridin-3-ylmethylene)hydrazinyl)quinoxaline

ID: ALA4643306

PubChem CID: 156017993

Max Phase: Preclinical

Molecular Formula: C14H11N5

Molecular Weight: 249.28

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C(=N/Nc1cnc2ccccc2n1)\c1cccnc1

Standard InChI:  InChI=1S/C14H11N5/c1-2-6-13-12(5-1)16-10-14(18-13)19-17-9-11-4-3-7-15-8-11/h1-10H,(H,18,19)/b17-9+

Standard InChI Key:  MGLSZIXYNXSQCJ-RQZCQDPDSA-N

Molfile:  

 
     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
   17.9809  -15.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9798  -16.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6878  -16.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6860  -14.8371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3946  -15.2423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3954  -16.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1039  -16.4684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8122  -16.0576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8075  -15.2355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0984  -14.8321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5127  -14.8226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2229  -15.2269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9281  -14.8140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6383  -15.2182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6389  -16.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3482  -16.4396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0544  -16.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0468  -15.2052    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3369  -14.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4643306

    ---

Associated Targets(Human)

OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 249.28Molecular Weight (Monoisotopic): 249.1014AlogP: 2.47#Rotatable Bonds: 3
Polar Surface Area: 63.06Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.78CX Basic pKa: 4.38CX LogP: 2.50CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.57Np Likeness Score: -1.78

References

1. Maranhão SS, Moura AF, Oliveira ACA, Lima DJB, Barros-Nepomuceno FWA, Paier CRK, Pinheiro AC, Nogueira TCM, de Souza MVN, Pessoa C..  (2020)  Synthesis of PJOV56, a new quinoxalinyl-hydrazone derivative able to induce autophagy and apoptosis in colorectal cancer cells, and related compounds.,  30  (2): [PMID:31836446] [10.1016/j.bmcl.2019.126851]

Source